Your browser doesn't support javascript.
loading
ASTEFANIA: adjuvant ado-trastuzumab emtansine and atezolizumab for high-risk, HER2-positive breast cancer.
Hurvitz, Sara A; Bachelot, Thomas; Bianchini, Giampaolo; Harbeck, Nadia; Loi, Sherene; Park, Yeon Hee; Prat, Aleix; Gilham, Leslie; Boulet, Thomas; Gochitashvili, Nino; Monturus, Estefania; Lambertini, Chiara; Nyawira, Beatrice; Knott, Adam; Restuccia, Eleonora; Schmid, Peter.
Afiliación
  • Hurvitz SA; University of California Los Angeles/Jonsson Comprehensive Cancer Centre (UCLA/JCCC), 10833 Le Conte Ave., Los Angeles, CA 900024, USA.
  • Bachelot T; Centre Léon Bérard, 28 Prom. Léa et Napoléon Bullukian, 69008, Lyon, France.
  • Bianchini G; IRCCS Ospedale San Raffaele, Via Olgettina, 60, Milano, MI, 20132, Italy.
  • Harbeck N; Department of Gynecology & Obstetrics & CCC Munich, Breast Center, LMU University Hospital, Marchioninistraße 15, 81377, Munich, Germany.
  • Loi S; Division of Cancer Research, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, Victoria, 3000, Australia.
  • Park YH; The Sir Peter MacCallum Department of Medical Oncology, University of Melbourne, Grattan Street, Parkville, Victoria, 3010, Australia.
  • Prat A; Samsung Medical Center, 81 Irwon-ro, Gangnam-gu, Seoul, South Korea.
  • Gilham L; Hospital Clínic Barcelona, C. de Villarroel, 170, 08036, Barcelona, Spain.
  • Boulet T; Patient advocate, Melbourne, VIC, Australia.
  • Gochitashvili N; F.Hoffmann-La Roche Ltd, Gartenstrasse 9, CH-4052, Basel, Switzerland.
  • Monturus E; Roche Products Limited, Hexagon Place, Shire Park, Falcon Way, Welwyn Garden City, AL7 1TW, UK.
  • Lambertini C; F.Hoffmann-La Roche Ltd, Gartenstrasse 9, CH-4052, Basel, Switzerland.
  • Nyawira B; F.Hoffmann-La Roche Ltd, Gartenstrasse 9, CH-4052, Basel, Switzerland.
  • Knott A; F.Hoffmann-La Roche Ltd, Gartenstrasse 9, CH-4052, Basel, Switzerland.
  • Restuccia E; Roche Products Limited, Hexagon Place, Shire Park, Falcon Way, Welwyn Garden City, AL7 1TW, UK.
  • Schmid P; F.Hoffmann-La Roche Ltd, Gartenstrasse 9, CH-4052, Basel, Switzerland.
Future Oncol ; 18(32): 3563-3572, 2022 Oct.
Article en En | MEDLINE | ID: mdl-36382554
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Future Oncol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Future Oncol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos